For the Inventor, By the Inventor

Enter assignee name

RAHWAY, NJ, United States of America

Merck Sharpe & Dohme Corp.

USPTO Granted Patents = 35

Forward Citations = 446

Loading Chart...

Loading Chart...

101 inventors (with patents filed for the assignee):

Raymond Baker (6 out of 63 patents)

Angus Murray MacLeod (4 out of 58 patents)

Mark Stewart Chambers (4 out of 43 patents)

4. Janusz Jozef Kulagowski (3 out of 73 patents)

5. Leslie Joseph Street (3 out of 70 patents)

6. Kevin John Merchant (3 out of 24 patents)

7. Paul John Whiting (3 out of 8 patents)

8. John Saunders (3 out of 12 patents)

9. Graham A Showell (3 out of 21 patents)

10. Guy R Humphrey (2 out of 30 patents)

11. William Robert Carling (2 out of 54 patents)

12. Michael Stewart Ashwood (2 out of 8 patents)

13. Beatrice Le Bourdelles (2 out of 4 patents)

14. Neil Roy Curtis (2 out of 33 patents)

15. Paul D Leeson (2 out of 36 patents)

35 patents: Sort by Forward Citations

1. 12037393 - P116 antibodies (2024-07-16),

2. 10570202 - Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer (2020-02-25),

3. 9828369 - Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 (2017-11-28),

4. 9145348 - Process for synthesizing a CETP inhibitor (2015-09-29),

5. 8957194 - 1B20 PCSK9 antagonists (2015-02-17),

6. 8592371 - Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2013-11-26),

7. 8293721 - CETP inhibitors derived from benzoxazole arylamides (2012-10-23),

8. 8168799 - Process for the preparation of tetrazolytetrahydrocyclopentapyrazoles (2012-05-01),

9. 7833992 - Conjugates and compositions for cellular delivery (2010-11-16),

10. 6696444 - Imidazo-triazine derivatives as ligands for GABA receptors (2004-02-24),

11. 6538008 - Combination of a selective NMDA NR2B antagonist and an opioid analgesic (2003-03-25),

12. 6310203 - Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands (2001-10-30),

13. 6156761 - Substituted tetralone derivatives for enhancing cognition (2000-12-05),

14. 6130058 - Human NMDA R2A receptor subunit and isoforms of the human NMDA-R1 (2000-10-10),

15. 6071909 - Phenylbenzimidazole derivatives as ligands for GABA receptors (2000-06-06),

Merck Sharpe & Dohme Corp. is a global pharmaceutical company that focuses on developing innovative treatments for a wide range of medical conditions. With a commitment to research and development, Merck Sharpe & Dohme Corp. strives to improve patient outcomes and enhance quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

35 Patents

#5 in RAHWAY, NJ

#387 in New Jersey

#9,422 in US

#18,610 in the World

RAHWAY, NJ, United States of America

Merck Sharpe & Dohme Corp.

Forward Citations = 446

101 inventors:

Raymond Baker (6 out of 63 patents)

Angus Murray MacLeod (4 out of 58 patents)

Mark Stewart Chambers (4 out of 43 patents)

4. Janusz Jozef Kulagowski (3 out of 73 patents)

5. Leslie Joseph Street (3 out of 70 patents)

Please report any incorrect information to support@idiyas.com

Loading…